Understanding The Connection Between Hypertension And Heart Enlargement
Published on: August 4, 2025
Understanding The Connection Between Hypertension And Heart Enlargement
  • Article author photo

    Nameerah Salman Rakhe

    Master's degree, Pharmacology, Shri. Vile Parle Kelvani Mandas Dr. Bhanuben Nanavati College of Pharmacy Vile Parle (W) Mumbai 400 056

Introduction

High blood pressure is also referred to as hypertension. It occurs when the force of your blood pressing against the walls of your blood vessels is excessive. High blood pressure can cause additional significant complications, including a heart attack and stroke.1 Globally, approximately 1.28 billion adults aged 30-79 have hypertension, with 2/3rd living in low and middle-income countries. About 46% of the population suffering from hypertension are unaware, and only 42% are diagnosed and treated. The impact of hypertension on global health underscores the urgent need for effective management strategies.2 

Cardiomegaly (or heart enlargement) refers to an increase in the size of the heart. Cardiomegaly can result from hypertension, heart valve disease, heart failure, or cardiomyopathy. An enlarged heart may not function efficiently, leading to further complications such as heart failure.3 

Persistent hypertension forces the heart to work harder to pump blood, increasing the strain on the heart muscle. Over time, this increased demand causes the heart muscle to thicken and enlarge, a condition known as cardiomegaly. While the heart can still pump blood, it becomes less efficient as it grows larger, ultimately leading to cardiovascular complications.4 

This article explores the relationship between hypertension related to heart enlargement, the underlying pathophysiology, clinical implications, diagnostic approach, and treatment strategies to enhance awareness and encourage proactive health management.

Understanding heart enlargement

Enlargement of the heart (cardiomegaly) is characterised by an increased width of the heart by 50% or more of the width of the chest, which can be seen on a chest x-ray or a CT scan. It often results from other underlying conditions, which make it harder for the heart to pump blood, resulting in the enlargement of the heart to compensate for the extra work. Cardiomegaly can present as various types of primary or acquired cardiomyopathy. For instance, dilated cardiomyopathy is marked by dilation of the left ventricle and reduced pumping ability, though it can also lead to right ventricular issues and problems with heart filling.5  Another common form is hypertrophic cardiomyopathy, where the heart muscles thicken (hypertrophied), making it harder for the heart to pump blood.6 

Cardiac hypertrophy can be classified as physiological. Physiological hypertrophy typically occurs during normal development, such as in children or pregnancy, and is common in athletes due to increased physical demands. In contrast, pathological hypertrophy is caused by prolonged hemodynamic stress, which is often due to conditions like hypertension or heart attacks.7

Hypertension: overview and pathophysiology

Hypertension is a condition where the blood pressure against the artery walls is consistently too high. Blood pressure readings consist of two numbers: systolic (the force of blood when the heart pumps) and diastolic (measured between heartbeats). A healthy systolic pressure is below 120mmHg, while a healthy diastolic pressure is below 80mmHg. Hypertension is diagnosed when systolic readings are consistently 130mmHg or higher, or when diastolic readings are 80mmHg or higher.8 

Hypertension is often referred to as a ‘silent killer’ because it usually has no symptoms until significant damage has occurred, making regular monitoring essential.9

The World Health Organisation estimated that nearly 1.4 billion adults have hypertension, with a significant proportion living in low and middle-income countries.

Pathophysiology of hypertension

Hypertension can develop through several mechanisms. One of the key factors is increased salt absorption, which causes the body to hold onto more water, leading to higher blood volume. Additionally, an impaired response of the renin-angiotensin-aldosterone system (RAAS), which helps regulate blood pressure, can contribute to the problem. Increased activation of the sympathetic nervous system, which controls the body’s stress response, also plays a role. Together, these changes result in higher total resistance in the blood vessel and increased workload on the heart, ultimately leading to hypertension.

Stages of hypertension

The American Heart Association and American College of Cardiology have categorised  hypertension into four general stages:

  1. Normal blood pressure (Ideal BP): blood pressure is lower than 120/80mmHg
  2. Elevated blood pressure: the systolic (upper) number ranges from 120-129mmHg and the diastolic number ranges below 80mmHg
  3. Stage 1 hypertension: the upper systolic number ranges from 130-139mmHg and the lower diastolic number ranges from 80-89mmHg
  4. Stage 2 hypertension: the upper systolic number ranges from 140mmHg or higher, and the lower diastolic number ranges from 90mmHg or higher
  5. Hypertensive crisis: blood pressure readings exceed 180/120mmHg, thereby requiring immediate medical attention10 

Risk factors

High blood pressure risk factors include:

  • Obesity 
  • Physical inactivity
  • Unhealthy diet (e.g. high sodium, low potassium)
  • Excessive alcohol consumption 
  • Tobacco use
  • Family history of hypertension 

Age, sex, and race can also contribute to the risk of developing hypertension. 

How does hypertension lead to heart enlargement?

Hypertension significantly impacts heart health, particularly by causing heart enlargement, known as left heart hypertrophy. When blood pressure remains elevated over time, it increases the workload on the left ventricle (the heart's main pumping chamber). To cope with this extra strain as an adaptive mechanism, the heart muscle thickens to maintain proper blood flow and delay heart failure.11 

Prolonged hypertension also triggers structural changes in the heart, including myocardial fibrosis, where the fibrous tissue builds up and stiffens the heart muscle. This can impair the heart's ability to function effectively.12 Also, neurohormonal regulation, which is the interaction between hormones and the nervous system, particularly in RAAS, worsens the situation by promoting fluid retention and increasing blood vessel constriction, further straining the heart.13  As the left ventricle adapts to this pressure overload, it can become stiffer and less capable of relaxing, leading to diastolic dysfunction, which is one of the first signs of heart changes.14  

Over time, these changes can increase the risk of heart failure, either with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF). Understanding the connection between hypertension and heart enlargement is therefore crucial for preventing serious cardiovascular issues and managing heart health effectively. 

Diagnosis of cardiomegaly in hypertensive patients

Heart enlargement often presents with clinical signs, such as shortness of breath, fatigue, chest pain, palpitations, and swelling (oedema).

Diagnostic methods include several imaging techniques and tests: 

  1. Electrocardiogram (ECG): This helps to reveal any sign of left or right ventricular hypertrophy, as well as any abnormalities
  2. Chest X-ray: used to identify heart enlargement by showing the enlarged cardiac silhouette. It can also differentiate which heart chambers are enlarged, based on specific patterns of the heart border displacement
  3. Echocardiography: An echocardiogram provides detailed information on ventricular size, wall thickness, and overall heart function. It can also provide information on the structure and function of the heart valves and detect ischemia-related changes
  4. Cardiac MRI: This advanced imaging process offers precise evaluation of both the left and right ventricles, allowing the characterisation of both ischemic and non-ischemic conditions
  5. Blood tests: Serum tests, including brain natriuretic peptide (BNP) and troponin levels, can help detect underlying cardiac issues5 

Treatment and management strategies

Managing heart enlargement effectively focuses on treating the underlying conditions contributing to the disease. The treatment approach is multifaceted; it combines lifestyle modifications and pharmacological treatments, and in some cases, surgical intervention.

  1. Lifestyle modifications: Lifestyle changes are a critical component in managing an enlarged heart, especially when hypertension or other preventable factors are involved, such as:
    • Weight management and regular exercise can help reduce the strain on the heart 
    • Adopting a healthy diet, such as the DASH diet (dietary approach to stop hypertension), which emphasises fruits, vegetables, and low-sodium foods, can help to control BP and reduce the burden on the heart
    • Limiting alcohol intake and smoking cessation are also key steps in preventing further damage to the heart
  2. Pharmacological treatments:
    • ACE inhibitors/ARBs: These drugs are used to reduce afterload (the resistance the heart must overcome to pump blood) and prevent further heart enlargement and hypertrophy
    • Beta-blockers: they help to control heart rate and blood pressure, relieving stress on the heart muscle
    • Diuretics: Diuretics help reduce fluid build-up in the body, which is particularly helpful when fluid retention is contributing to the heart's enlargement
    • Mineralocorticoid receptor antagonists (MRAs): These drugs can help reduce fluid retention and improve heart function, especially in patients with heart failure
  3. Surgical and interventional treatments: surgical interventions include: 
    • A pacemaker to regulate the heart rate
    • An implantable cardioverter-defibrillator (ICD) to correct arrhythmias
    • Heart valve surgery to repair or replace damaged valves
    • Coronary bypass surgery to reroute blood flow around blocked arteries
    • A left ventricular assist device (LVAD) to help the heart pump blood
    • Heart transplant (if other treatments fail and the patient is a candidate)15

Summary

Hypertension can cause heart enlargement, increasing the heart's workload and leading to complications like heart failure. Prolonged high blood pressure triggers structural changes in the heart, such as hypertrophy and fibrosis, impairing its function. Effective management includes lifestyle changes, medications, and in some cases, surgical interventions to reduce stress and improve heart function. 

References 

  1. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of Hypertension. Ann Intern Med [Internet]. 2003 [cited 2025 Aug 3]; 139(9):761–76. Available from: https://www.acpjournals.org/doi/10.7326/0003-4819-139-9-200311040-00011 
  2. Amin H, Siddiqui WJ. Cardiomegaly. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Nov 12]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK542296/ 
  3. Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology [Internet]. 2016 [cited 2025 Aug 3]; 97:245–62. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022282816301493 
  4. High blood pressure - what is high blood pressure? | nhlbi, nih [Internet]. 2024 [cited 2024 Nov 12]. Available from: https://www.nhlbi.nih.gov/health/high-blood-pressure 
  5. Díez J. Mechanisms of cardiac fibrosis in hypertension. The Journal of Clinical Hypertension [Internet]. 2007 Jul 2 [cited 2024 Nov 12];9(7):546. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8110048/ 
  6. Manolis AA, Manolis TA, Manolis AS. Neurohumoral activation in heart failure. International Journal of Molecular Sciences [Internet]. 2023 Jan [cited 2024 Nov 12];24(20):15472. Available from: https://www.mdpi.com/1422-0067/24/20/15472 
  7. Bromfield S, Muntner P. High Blood Pressure: The Leading Global Burden of Disease Risk Factor and the Need for Worldwide Prevention Programs. Curr Hypertens Rep [Internet]. 2013 [cited 2025 Aug 3]; 15(3):134–6. Available from: https://doi.org/10.1007/s11906-013-0340-9
Share

Nameerah Salman Rakhe

Master's degree, Pharmacology, Shri. Vile Parle Kelvani Mandas Dr. Bhanuben Nanavati College of Pharmacy Vile Parle (W) Mumbai 400 056

arrow-right